Figures & data
Table I. Patient characteristics.
Table II. Treatment of non-metastatic osteosarcoma/MFH (n = 146) and Ewing family of tumours (n = 44).
Figure 2. Sarcoma specific survival for non-metastatic osteosarcoma and Ekring's sarcoma by period of diagnosis.
![Figure 2. Sarcoma specific survival for non-metastatic osteosarcoma and Ekring's sarcoma by period of diagnosis.](/cms/asset/ec9ed5da-846c-4eb0-a601-f0f3dd59b42d/ionc_a_146645_f0002_b.jpg)
Table III. Development over time in five-year sarcoma-specific survival in different patient and tumour categories.
Table IV. Favourable prognostic factors for sarcoma specific survival (195 OS and ES patients with complete data).
Table V. Favourable prognostic factors for patients with localized disease at diagnosis (154 OS and ES patients with complete data).